Tehran University of Medical Sciences

Science Communicator Platform

Share By
Synthesis and Biological Evaluations of New 4,5-Diphenyl-Imidazole-Indole-N-Phenylacetamide Derivatives Against Α-Glucosidase and Acetylcholinesterase Publisher Pubmed



Ghafouri S N ; Halimi M ; Dastyafteh N ; Behzad C ; Ebrahimi S M ; Aghaei Khouzani M ; Noori M ; Aktas A ; Sadeghian N ; Dadgar A ; Larijani B ; Mohammadi Khanaposhtani M ; Taslimi P ; Firuzi O Show All Authors
Authors
  1. Ghafouri S N
  2. Halimi M
  3. Dastyafteh N
  4. Behzad C
  5. Ebrahimi S M
  6. Aghaei Khouzani M
  7. Noori M
  8. Aktas A
  9. Sadeghian N
  10. Dadgar A
  11. Larijani B
  12. Mohammadi Khanaposhtani M
  13. Taslimi P
  14. Firuzi O
  15. Mahdavi M

Source: Archiv der Pharmazie Published:2026


Abstract

A novel series of 4,5-diphenyl-imidazole-indole-N-phenylacetamide derivatives (6a-m) was designed, synthesized, and evaluated for their inhibitory activities against α-glucosidase and acetylcholinesterase (AChE). Among the thirteen derivatives, nine were more potent than the standard α-glucosidase inhibitor (acarbose), and eleven showed higher potency than the standard AChE inhibitor (tacrine). The most effective compound against α-glucosidase was compound 6l, which demonstrated a 2.1-fold higher potency compared to acarbose. The best compound against AChE was compound 6j, which was 16.9-fold more potent than tacrine. Given that the compounds showed stronger inhibitory activity against AChE than against α-glucosidase, compound 6j, identified as the best AChE inhibitor, was selected for further investigation. Kinetic studies revealed that compound 6j is a competitive inhibitor of AChE. Molecular docking and dynamics simulations confirmed the stability of compound 6j within the active site of AChE. Additionally, compound 6j demonstrated no cytotoxicity at its effective dose against AChE in the normal cell line NIH-3T3, confirming its favorable safety profile at high concentrations. © 2026 Deutsche Pharmazeutische Gesellschaft.
Related Docs
View other Related Docs
1. Alpha-Glucosidase Inhibitory and Hypoglycemic Effects of Imidazole-Bearing Thioquinoline Derivatives With Different Substituents: In Silico, in Vitro, and in Vivo Evaluations, Bioorganic Chemistry (2024)
2. Novel Tacrine-1,2,3-Triazole Hybrids: In Vitro, in Vivo Biological Evaluation and Docking Study of Cholinesterase Inhibitors, European Journal of Medicinal Chemistry (2017)
3. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs As Potent Anti-Alzheimer's Agents, Chemistry and Biodiversity (2019)
Experts (# of related papers)
View all Related Experts
Mohammad Mahdavi (13)
Bagher Larijani (8)
Other Related Docs
4. Development and Validation of Type 2 Diabetic Zebrafish Model for Cell-Based Treatments, Methods in Molecular Biology (2024)
5. Novel Tacrine-Coumarin Hybrids Linked to 1,2,3-Triazole As Anti-Alzheimer's Compounds: In Vitro and in Vivo Biological Evaluation and Docking Study, Bioorganic Chemistry (2019)
6. Synthesis, Docking Study, and Biological Evaluation of Novel Umbellipherone/Hymecromone Derivatives As Acetylcholinesterase/Butyrylcholinesterase Inhibitors, Medicinal Chemistry Research (2018)
7. Design and Synthesis of Novel Anti-Alzheimer's Agents: Acridine-Chromenone and Quinoline-Chromenone Hybrids, Bioorganic Chemistry (2016)
8. Design, Synthesis, Characterization, Enzymatic Inhibition Evaluations, and Docking Study of Novel Quinazolinone Derivatives, International Journal of Biological Macromolecules (2021)
9. 4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study, Structural Chemistry (2020)
10. Design, Synthesis, in Vitro and in Silico Biological Assays of New Quinazolinone-2-Thio-Metronidazole Derivatives, Journal of Molecular Structure (2021)
11. Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives, Chemistry and Biodiversity (2019)
12. Synthesis and Α-Glucosidase Inhibitory Activity of Ethyl 3-Coumarincarboxylate-1,2,3-Triazole-N-Phenylacetamide Derivatives, ChemistrySelect (2026)
13. New Benzyl Pyridinium Derivatives Bearing 2,4-Dioxochroman Moiety As Potent Agents for Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Docking Study, Bioorganic Chemistry (2019)
14. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-Carboxamide-N-Morpholine Hybrids As New Anti-Alzheimer Agents, Chemistry and Biodiversity (2019)
15. Imidazo[1,2-C]Quinazolines As a Novel and Potent Scaffold of Α-Glucosidase Inhibitors: Design, Synthesis, Biological Evaluations, and in Silico Studies, Scientific Reports (2023)
16. Dual Functional Cholinesterase and Carbonic Anhydrase Inhibitors for the Treatment of Alzheimer's Disease: Design, Synthesis, in Vitro, and in Silico Evaluations of Coumarin-Dihydropyridine Derivatives, Journal of Molecular Structure (2023)